相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Analysis of PIK3CA and B-RAF gene mutations in human astrocytomas: association with activation of ERK and AKT
E.A. El-Habr et al.
CLINICAL NEUROPATHOLOGY (2011)
Association of molecular alterations, including BRAF, with biology and outcome in pilocytic astrocytomas
Craig Horbinski et al.
ACTA NEUROPATHOLOGICA (2010)
RG7204 (PLX4032), a Selective BRAFV600E Inhibitor, Displays Potent Antitumor Activity in Preclinical Melanoma Models
Hong Yang et al.
CANCER RESEARCH (2010)
Oncogenic BRAF Mutation with CDKN2A Inactivation Is Characteristic of a Subset of Pediatric Malignant Astrocytomas
Joshua D. Schiffman et al.
CANCER RESEARCH (2010)
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
Keith T. Flaherty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Activated BRAF induces gliomas in mice when combined with Ink4a/Arf loss or Akt activation
J. P. Robinson et al.
ONCOGENE (2010)
Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma
Andrey Korshunov et al.
ACTA NEUROPATHOLOGICA (2009)
Pleomorphic xanthoastrocytoma as a component of a temporal lobe cystic ganglioglioma: a case report
Yasuo Sugita et al.
BRAIN TUMOR PATHOLOGY (2009)
Duplication of 7q34 is specific to juvenile pilocytic astrocytomas and a hallmark of cerebellar and optic pathway tumours
K. Jacob et al.
BRITISH JOURNAL OF CANCER (2009)
Targeting the RAF-MEK-ERK pathway in cancer therapy
Clara Montagut et al.
CANCER LETTERS (2009)
Antitumor Efficacy of the Novel RAF Inhibitor GDC-0879 Is Predicted by BRAFV600E Mutational Status and Sustained Extracellular Signal-Regulated Kinase/Mitogen-Activated Protein Kinase Pathway Suppression
Klaus P. Hoeflich et al.
CANCER RESEARCH (2009)
Activation of the ERK/MAPK pathway: a signature genetic defect in posterior fossa pilocytic astrocytomas
Tim Forshew et al.
JOURNAL OF PATHOLOGY (2009)
Alterations of BRAF and HIPK2 loci predominate in sporadic pilocytic astrocytoma
J. Yu et al.
NEUROLOGY (2009)
Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549:BRAF fusion in activating the MAPK pathway in pilocytic astrocytoma
D. T. W. Jones et al.
ONCOGENE (2009)
Resequencing Analysis of the Human Tyrosine Kinase Gene Family in Pancreatic Cancer
Takashi Kubo et al.
PANCREAS (2009)
Tandem Duplication Producing a Novel Oncogenic BRAF Fusion Gene Defines the Majority of Pilocytic Astrocytomas
David T. W. Jones et al.
CANCER RESEARCH (2008)
BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas
Stefan Pfister et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
BRAFE600 in benign and malignant human tumours
C. Michaloglou et al.
ONCOGENE (2008)
Atypical teratoid/rhabdoid tumor arising in the setting of a pleomorphic xanthoastrocytoma
Geeta Chacko et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
RAS/RAF pathway activation in gliomas: the result of copy number gains rather than activating mutations
Judith Jeuken et al.
ACTA NEUROPATHOLOGICA (2007)
A mutation and expression analysis of the oncogene BRAF in pituitary adenomas
Iain Ewing et al.
CLINICAL ENDOCRINOLOGY (2007)
Frequent loss of chromosome 9, homozygous CDKN2A/p14ARF/CDKN2B deletion and low TSC1 mRNA expression in pleomorphic xanthoastrocytomas
R. G. Weber et al.
ONCOGENE (2007)
Atypical teratoid/rhabdoid tumor evolving from an optic pathway ganglioglioma: Case study
JC Allen et al.
NEURO-ONCOLOGY (2006)
BRAFE600-associated senescence-like cell cycle arrest of human naevi
C Michaloglou et al.
NATURE (2005)
Mutation analysis of B-RAF gene in human gliomas
D Basto et al.
ACTA NEUROPATHOLOGICA (2005)
Mutation analysis of the Ras pathway genes NRAS, HRAS, KRAS and BRAF in glioblastomas
CB Knobbe et al.
ACTA NEUROPATHOLOGICA (2004)
Study of the MIB-1 Labeling index as a predictor of tumor progression in pilocytic astrocytomas in children and adolescents
DC Bowers et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Mutations of the BRAF gene in cholangiocarcinoma but not in hepatocellular carcinoma
A Tannapfel et al.
GUT (2003)
Mutations of the BRAF gene in human cancer
H Davies et al.
NATURE (2002)